191 related articles for article (PubMed ID: 9186870)
1. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats.
Chadban SJ; Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 1997 Jun; 51(6):1809-17. PubMed ID: 9186870
[TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental crescentic glomerulonephritis by deoxyspergualin.
Lan HY; Zarama M; Nikolic-Paterson DJ; Kerr PG; Atkins RC
J Am Soc Nephrol; 1993 May; 3(11):1765-74. PubMed ID: 8329671
[TBL] [Abstract][Full Text] [Related]
3. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
Lan HY; Bacher M; Yang N; Mu W; Nikolic-Paterson DJ; Metz C; Meinhardt A; Bucala R; Atkins RC
J Exp Med; 1997 Apr; 185(8):1455-65. PubMed ID: 9126926
[TBL] [Abstract][Full Text] [Related]
4. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis.
Tipping PG; Kitching AR; Huang XR; Mutch DA; Holdsworth SR
Eur J Immunol; 1997 Feb; 27(2):530-7. PubMed ID: 9045927
[TBL] [Abstract][Full Text] [Related]
5. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist.
Lan HY; Nikolic-Paterson DJ; Zarama M; Vannice JL; Atkins RC
Kidney Int; 1993 Feb; 43(2):479-85. PubMed ID: 8441245
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
Tang WW; Feng L; Vannice JL; Wilson CB
J Clin Invest; 1994 Jan; 93(1):273-9. PubMed ID: 7904269
[TBL] [Abstract][Full Text] [Related]
7. Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation.
Huang XR; Holdsworth SR; Tipping PG
Kidney Int; 1994 Jul; 46(1):69-78. PubMed ID: 7523756
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice.
Kitching AR; Tipping PG; Huang XR; Mutch DA; Holdsworth SR
Kidney Int; 1997 Jul; 52(1):52-9. PubMed ID: 9211346
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis.
Lan HY; Yang N; Metz C; Mu W; Song Q; Nikolic-Paterson DJ; Bacher M; Bucala R; Atkins RC
Mol Med; 1997 Feb; 3(2):136-44. PubMed ID: 9085256
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD
Kidney Int; 1999 Apr; 55(4):1319-26. PubMed ID: 10200996
[TBL] [Abstract][Full Text] [Related]
11. c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat.
Han Y; Ma FY; Tesch GH; Manthey CL; Nikolic-Paterson DJ
Lab Invest; 2011 Jul; 91(7):978-91. PubMed ID: 21519331
[TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
[TBL] [Abstract][Full Text] [Related]
13. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.
Kitching AR; Tipping PG; Timoshanko JR; Holdsworth SR
Kidney Int; 2000 Feb; 57(2):518-25. PubMed ID: 10652028
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat.
Ma FY; Flanc RS; Tesch GH; Bennett BL; Friedman GC; Nikolic-Paterson DJ
Lab Invest; 2009 Apr; 89(4):470-84. PubMed ID: 19188913
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat.
Lan HY; Nikolic-Paterson DJ; Mu W; Vannice JL; Atkins RC
Kidney Int; 1995 May; 47(5):1303-9. PubMed ID: 7637259
[TBL] [Abstract][Full Text] [Related]
16. Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production.
Yang N; Nikolic-Paterson DJ; Ng YY; Mu W; Metz C; Bacher M; Meinhardt A; Bucala R; Atkins RC; Lan HY
Mol Med; 1998 Jun; 4(6):413-24. PubMed ID: 10780884
[TBL] [Abstract][Full Text] [Related]
17. Abrogation of glomerular injury in nephrotoxic nephritis by continuous infusion of interleukin-6.
Karkar AM; Smith J; Tam FW; Pusey CD; Rees AJ
Kidney Int; 1997 Nov; 52(5):1313-20. PubMed ID: 9350654
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G
J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney.
Tesch GH; Yang N; Yu H; Lan HY; Foti R; Chadban SJ; Atkins RC; Nikolic-Paterson DJ
Nephrol Dial Transplant; 1997 Jun; 12(6):1109-15. PubMed ID: 9198037
[TBL] [Abstract][Full Text] [Related]
20. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
Liu D; Nazneen A; Taguchi T; Razzaque MS
Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
